Get the Stockscreener App
106.45
1.13%
1.19
After Hours:
106.47
0.02
+0.02%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $106.45, with a volume of 9.99M.
It is up +1.13% in the last 24 hours and up +5.36% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$105.26
Open:
$105.53
24h Volume:
9.99M
Relative Volume:
0.74
Market Cap:
$264.21B
Revenue:
$63.90B
Net Income/Loss:
$19.05B
P/E Ratio:
14.08
EPS:
7.5596
Net Cash Flow:
$13.05B
1W Performance:
-0.31%
1M Performance:
+5.36%
6M Performance:
+29.20%
1Y Performance:
+7.34%
1-Day Range:
$104.43
$106.62
1-Week Range:
$104.43
$107.59
52-Week Range:
$73.31
$107.59
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
106.45 | 261.26B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,080.36 | 961.86B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.35 | 498.60B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
229.31 | 403.83B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
138.54 | 264.54B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co. Inc.: How a 130-Year Pharma Giant Is Rebuilding Its Flagship Around Oncology and Beyond - AD HOC NEWS
Asset Management One Co. Ltd. Purchases 55,089 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Synergy Asset Management LLC Has $6.84 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading 1.2% HigherTime to Buy? - MarketBeat
Merck & Co (NYSE:MRK) Sees Institutional Ownership Changes Filed - Kalkine Media
PICTET BANK & TRUST Ltd Decreases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
SteelPeak Wealth LLC Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Retirement Guys Formula LLC - MarketBeat
Tectonic Advisors LLC Buys 23,294 Shares of Merck & Co., Inc. $MRK - MarketBeat
Lazard Freres Gestion S.A.S. Invests $98.35 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Ninety One UK Ltd - MarketBeat
Econ Financial Services Corp Takes $2.04 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Raised by Generali Asset Management SPA SGR - MarketBeat
Allspring Global Investments Holdings LLC Purchases 147,220 Shares of Merck & Co., Inc. $MRK - MarketBeat
Banque Pictet & Cie SA Sells 246,821 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ninety One SA PTY Ltd Acquires New Position in Merck & Co., Inc. $MRK - MarketBeat
Romano Brothers AND Company Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Northwest Capital Management Inc - MarketBeat
Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook - Seeking Alpha
Merck: Framework For Success (NYSE:MRK) - Seeking Alpha
Merck stock dips after hours as 2025 ends; MRK investors shift focus to Feb. 3 earnings - ts2.tech
Where is Merck & Co. (MRK) headed? - MSN
Where is Merck & Co. (MRK) Headed? - Finviz
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Los Angeles Capital Management LLC Buys 956,879 Shares of Merck & Co., Inc. $MRK - MarketBeat
Stonebridge Financial Group LLC Has $638,000 Position in Merck & Co., Inc. $MRK - MarketBeat
Sax Wealth Advisors LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Has $126.51 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Smith Salley Wealth Management Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Calamos Advisors LLC Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by 3Chopt Investment Partners LLC - MarketBeat
FDA fast-tracks two Merck (MRK) drugs with blockbuster potential - MSN
FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential - Finviz
Merck: A Post-2028 Slowdown Doesn’t Kill The Long-Term Thesis (NYSE:MRK) - Seeking Alpha
Oak Harvest Investment Services Purchases 24,325 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fort Washington Investment Advisors Inc. OH Has $51.42 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Hits New 1-Year HighHere's What Happened - MarketBeat
Diversified Trust Co Purchases 18,187 Shares of Merck & Co., Inc. $MRK - MarketBeat
Chemung Canal Trust Co. Buys 13,285 Shares of Merck & Co., Inc. $MRK - MarketBeat
Farmers & Merchants Investments Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) S&P 500 ETF Scientific Infrastructure - Kalkine Media
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Where is Merck & Co. (MRK) Headed According to Wall Street? - Finviz
November phase III successes led by HIV wins from Gilead, Merck - BioWorld MedTech
Merck & Co Unusual Options Activity - Benzinga
Norris Perne & French LLP MI Sells 36,819 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Ethic Inc. - MarketBeat
Merck (MRK) Stock Today: Latest News, Analyst Forecasts, and What Investors Should Watch Before Monday’s Open - ts2.tech
Valley National Advisers Inc. Acquires 25,843 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):